제1형 양극성 장애와 Lymphotoxin Alpha 유전자 단일염기 다형성 연관 연구 = Association Study of Single-Nucleotide Polymorphism in Lymphotoxin Alpha Gene and Bipolar I Disorder

다국어 초록 (Multilingual Abstract)

Objectives : Proinflammatory process has been implicated as an underlying mechanism of bipolar disorder and schizophrenia. Previous studies have suggested a possible role of lymphotoxin alpha (LTA) gene in the development of schizophrenia and have prompted further investigation in bipolar patients. Association of the LTA +252A/G polymorphism with susceptibility to bipolar I disorder itself as well as with vulnerability among a subset of psychotic bipolar patients were tested. Methods : DNA extraction was done by a standard method and genotyping was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 114 Korean patients with bipolar I disorder and 202 healthy controls. SPSS v18.0 was used for statistical analysis. Comparisons of the genotype and allele distributions in LTA +252A/G polymorphism were made using a chi-square test. The genotype and allele associations were also evaluated using odds ratio (OR) and 95% confidence interval (CI). Statistical significance was accepted when p was < 0.05. Results : No significant association was found between the LTA +252A/G polymorphism and bipolar disorder. However, LTA +252G allele was present with significantly higher frequency among bipolar patients with psychotic features compared to those without (${\chi}^2$ = 4.69, p = 0.034, OR = 2.495, 95% CI = 1.069-5.827). Conclusion : The results suggest that the allele LTA +252G of the polymorphism may be associated with the psychotic subset of bipolar disorder but not with bipolar I disorder itself. Adequately powered subsequent studies should be conducted.

참고문헌 (Reference)

1 Cheng B, "Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis" 12 : 139-153, 1994

2 Denicoff KD, "The neuropsychiatric effects of treatment with interleukin- 2 and lymphokine-activated killer cells" 107 : 293-300, 1987

3 McGuffin P, "The heritability of bipolar affective disorder and the genetic relationship to unipolar depression" 60 : 497-502, 2003

4 Craddock N, "The genetics of schizophrenia and bipolar disorder: dissecting psychosis" 42 : 193-204, 2005

5 Serretti A, "The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions" 13 : 742-771, 2008

6 Whichelow CE, "The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls" 23 : 425-435, 1996

7 Jun TY, "TNFB polymorphism may be associated with schizophrenia in the Korean population" 61 : 39-45, 2003

8 Cao Q, "Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees" 43 : 1-8, 1997

9 Kunz M, "Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance" 33 : 268-274, 2011

10 Pope HG Jr, "Schizophrenic individuals with bipolar first-degree relatives: analysis of two pedigrees" 51 : 97-101, 1990

11 Owen MJ, "Schizophrenia: genes at last?" 21 : 518-525, 2005

12 Straub RE, "Schizophrenia genes - famine to feast" 60 : 81-83, 2006

13 Pearce BD, "Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms" 6 : 634-646, 2001

14 Keso T, "Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men" 154 : 691-697, 2001

15 García-Elorriaga G, "Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment" 33 : 267-275, 2010

16 Messer G, "Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production" 173 : 209-219, 1991

17 Ross CA, "Neurobiology of schizophrenia" 52 : 139-153, 2006

18 Sadock BJ, "Mood disorders, In Kaplan & Sadock’s Synopsos of Psychiatry. 10th ed" Lippincott Williams & Wilkins, a Wolters Kluwer Business 527-568, 2007

19 Mood disorders work group, "Mood disorders, In Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision" American Psychiatric Association 345-428, 2000

20 Riley B, "Molecular genetic studies of schizophrenia" 14 : 669-680, 2006

21 Buka SL, "Maternal cytokine levels during pregnancy and adult psychosis" 15 : 411-420, 2001

22 Schulze TG, "Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees" 56 : 18-23, 2004

23 Park N, "Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia" 9 : 1091-1099, 2004

24 Vallès V, "Increased morbid risk for schizophrenia in families of in-patients with bipolar illness" 42 : 83-90, 2000

25 Dick DM, "Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative" 73 : 107-114, 2003

26 Craddock N, "Genetics of bipolar disorder: successful start to a long journey" 25 : 99-105, 2009

27 Craddock N, "Genetics of bipolar disorder" 36 : 585-594, 1999

28 Ozaki K, "Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction" 32 : 650-654, 2002

29 엄재영, "Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population" BLACKWELL PUBLISHING 139 : 184-188, 2003

30 Berrettini W, "Evidence for shared susceptibility in bipolar disorder and schizophrenia" 123C : 59-64, 2003

31 Wildenauer DB, "Do schizophrenia and affective disorder share susceptibility genes?" 39 : 107-160, 1999

32 Boukhris W, "Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro" 10 : 501-512, 1988

33 Cazzullo CL, "Cytokines production in chronic schizophrenia patients with or without paranoid behaviour" 22 : 947-957, 1998

34 Cazzullo CL, "Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study" 26 : 33-39, 2002

35 Balding J, "Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity" 48 : 1408-1413, 2003

36 Sestak AL, "Current status of lupus genetics" 9 : 210-, 2007

37 Brietzke E, "Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder" 116 : 214-217, 2009

38 Raybould R, "Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1)" 57 : 696-701, 2005

39 Prata DP, "An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis" 19 : 113-116, 2009

40 Knight JC, "Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1" 36 : 394-399, 2004

41 Tsai SY, "Activation of indices of cell-mediated immunity in bipolar mania" 45 : 989-994, 1999

42 Miller SA, "A simple salting out procedure for extracting DNA from human nucleated cells" 16 : 1215-, 1988

43 Straub RE, "A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity" 11 : 287-293, 1995

44 Shirts BH, "A comprehensive genetic association and functional study of TNF in schizophrenia risk" 83 : 7-13, 2006